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ABSTRACT 
Objective: The present work aimed to investigate the phytochemical constituents and antibacterial activity of several extracts of Acacia 
ataxacantha bark on pathogenic microbes. 
Methods: The phytochemical study was performed using tube test and Thin layer chromatography methods. The growth inhibitory effect and the 
Minimum Inhibitory Concentration of hexane, dichloromethane, ethyl acetate, methanol and hydroalcolic extracts were determined using the 
microplate dilution method.  
Results: Phytochemical screening revealed the presence of alkaloid, tannins, lignan, triterpenoids, anthracene derivatives, flavonoids, saponins and 
coumarins at different level. The extracts exhibited different effect against the tested bacteria. The minimum inhibitory concentrations of extracts 
ranged from 325 µg/ml to 5 mg/ml. Ethyl acetate extract was more potent than other extracts with the MIC values of 325 µg/ml against S. aureus 
and 625 µg/ml against all other tested bacteria. Escherichia coli was resistant to all extracts.  
Conlusion: These findings suggest that the rich phytochemical content of Acacia ataxacantha and its good antibacterial activity may be responsible 
for its popular and wide traditional use. 
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INTRODUCTION 
Infectious diseases are becoming a crisis as a major cause of 
mortality and human and animal morbidity [1]. They cause massive 
mortality in developing countries due to the extreme poverty of the 
population compared to developed countries. This situation is 
aggravated by the lack of appropriate vaccine, inaccessibility and/or 
the absence of antibiotics and the emergence of antibiotic resistant 
strains. Many efforts have been made by researchers to discover 
new antibacterial compound. One important source of discovery of 
the antibacterial drugs is medicinal plants through traditional 
medicines. Traditional treatments have been investigated and a 
significant success was achieved. In addition, it is known that, unlike 
synthetic drugs, antimicrobials of plant origin are not associated 
with many side effects and have an enormous therapeutic potential 
to cure many infectious diseases [2, 3]. 
The use of herbal medicine in Benin is a long history of human 
interaction with the environment. The plants used in traditional 
medicine contain a wide range of substances that can be used to 
treat chronic and infectious diseases. Acacia species have had a long 
history of medicinal use in the treatment of diarrhea, urinary 
infections, throat inflammation, gastritis, tuberculosis and 
headaches [4]. 
Acacia Ataxacantha (Fabaceae) is widespread in much of sub-
Saharan Africa. This species is a very thorny shrub scandent 5 to 8 m 
in height. The leaves are alternate, pinnate with spine that carries 5 
to 12 pairs of pinnae. On twigs, spines are short, clearly pointing 
down. The white flowers with a long transition axillary 4 to 5 cm 
long and arranged on stem 10 to 15 mm are sometimes isolated in 
pairs. The fruit pods are flattened, brownish red in the dry state. The 
dough sheet is used topically in the treatment of abscesses. The leaf 
decoction is used orally in febrile convulsions. Its bark is used 
against tooth decay, by inhalation in case of bronchitis and cough 
[5]. In Nigeria, pods and seeds of Acacia ataxacantha were also used 
against dysentery [6]. The roots are used in Kenya in the treatment 
of joint and back pain [7]. Acacia ataxacantha is also known for the 
treatment of pneumonia [8]. 
In the best of our knowledge, there is no scientific information 
concerning the in vitro antibacterial activity of this medicinal plant.  
In our search for natural products with antibacterial activity, we 
investigated a traditional plant used in Benin (West Africa) to treat 
infectious diseases. Polar and apolar extracts were prepared from 
selected plant and then evaluated for in vitro antibacterial activity 
against four Gram positive and two Gram negative bacteria. First, by 
assessing the ability of each extract to inhibit the growth of bacteria 
at a concentration of 10 mg/ml, secondly, by determined the 
Minimum Inhibitory Concentration and total activity of extracts. The 
chemical constituent of the plant was also determined.  
MATERIALS AND METHODS 
Plant material 
The barks of Acacia ataxacantha were collected in September 2012 
from Ouidah, Department of Atlantic, South Bénin. Botanical 
determination was performed by taxonomists from the Herbier 
National of Abomey-Calavi University in Benin and voucher 
specimens were deposited at the same herbarium (AA 6509/ HNB). 
The collected material was dried for two weeks in the laboratory 
(22°C) and ground to a fine powder using an electric grinder (Excella 
mixer grinder). 
Preparation of the extracts 
Two hundred and fifty grams (250 g) of dry powder of the barks of 
Acacia ataxacantha were successively extracted by maceration with 
hexane, dichloromethane, ethyl acetate and methanol for 72 h 
stirring. Fifty grams (50 g) of dry powder was also extracted with a 
mixture of ethanol-water (20:80). Each extraction is repeated three 
times. The macerates were filtered and concentrated using a rotary 
evaporator (RE 300, stuart) and the extracts were stored at 4° C 
until biological assay. 
Phytochemical analysis  
Phytochemical screening of the plant was carried out according to 
the methods described by Wagner and Blat [9] and Bruneton [10] 
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for the detection of plant secondary metabolites. Tannins, alkaloids, 
flavonoids, steroids, coumarins, saponins, naphthoquinones, 
triterpenes, lignans, pigments, anthracene derivatives have been 
investigated using tube test. Each extract (10 mg/ml) were 
deposited on TLC plate to confirm the results. 
Antibacterial activity 
Bacterial strains 
Several extracts of acacia ataxacantha bark were individually tested 
against a panel of bacteria including four Gram-positive: 
Staphylococcus aureus (ATCC 6538), S. epidermidis (CIP8039), 
Enterococcus faecalis (ATCC 29212), Staphylococcus aureus Methicillin 
Resistant (SARM) and two Gram-negative: Escherichia coli (CIP 53126) 
and Pseudomonas aeruginosa (CIP82118) obtained from Laboratoire 
de Biophotonique et Pharmacologie, University of Strasbourg, France. 
Growth inhibition effect of extracts at 10 mg/ml 
Sensivity of different bacterial strains to various extracts was 
determined using 96-well microplate. The aim of this method was to 
eliminate the extracts, which at 10 mg/ml do not inhibit the growth 
of bacteria [11]. The extracts were reconstituted to a concentration 
of 20 mg/ml in acetone/Muller Hinton broth culture. A volume of 
100 μL of each extract (20 mg/ml) was introduced in triplicate 
microplate already seeded with 100 μL of the Muller Hinton broth 
culture inoculums (106
Minimum Inhibitory Concentration (MIC) 
CFU/ml) of the tested bacteria. The microplate 
was incubated at 37°C. After 18 h of incubation, 40 μL of 0.2 mg/ml 
solution of p-iodonitrotetrazolium (Sigma Aldrich) were added to each 
well and microplate was incubated at 37°C. Finally, after 30 min, the 
color change (extract color to red) of mix in each well was examined to 
select actives extracts. Active extract do not change color. 
The Minimum Inhibitory Concentrations (MICs) of antibacterial 
(sensitive bacterial) activity were determined by the method of 
broth microdilution using p-iodonitrotetrazolium (INT) as an 
indicator of bacterial viability [12]. To determine the MIC of extracts, 
100 μl of Mueller Hinton broth (DIFCO) were added to each wells of 
a 96-wells microplate and then 100 μl of plant extract (20 mg/ml) 
were added to the first well (A) of the plate. A two-fold Successive 
dilution was carried from well (A) to the last wells (H) of the plate. 
Then, 100μl of bacterial broth at 106
Total activity 
CFU/ml were finally added into 
all the wells. The plate was covered and incubated at 37°C. After 18 h 
of incubation, 40 μl of p-iodonitrotétrazolium (0.2 %) was added in 
all wells and the plates were incubated again at 37°C. After 1 h of 
incubation, wells were examined and the MIC values were recorded. 
To select the extracts that can be used for further testing, the 
determination of the total activity is important because since the 
MIC value is inversely proportional to the amount of antimicrobial 
extracts. The total activity of each extract was calculated by dividing 
the MICs with the amount of extract obtained from 1 g of plant 
material [13]. This value indicates the volume in which the active 
principle (extract) present in 1 g of dry plant material can be diluted 
to always have inhibitory activity against organisms [14]. 
 
Table 1: Phytochemical constituents of bark extracts from A. ataxacantha 
 Plant extracts 
Phytochemical component Hex CH2Cl AcOEt 2 MeOH H2O/Et 
Coumarin + + + + + 
Flavonoid - + ++ + + 
Naphtoquinone - ++ ++ - - 
Alkaloid - + + + + 
anthracene derivative  - + + + + 
saponin - - + + + 
lignan + + + ++ + 
triterpene - ++ + + + 
tannin - + + + + 
Pigment + + + + - 
Hex: hexane, CH2Cl2:dichloromethane, AcOEt: ethyl acetate, MeOH: Methanol, H2
 
O/Et: hydroalcolic; (+) = present in moderate concentration, (++) = 
present in high concentration, (-) = indicates the absence of the compound tested. 
Table 2: Antibacterial activity of bark extracts from A. ataxacantha at 10 mg/ml 
 Growth inhibition effect of extract at 10 mg/ml 
Extracts Gram (+)  Gram (-) 
S. aureus S. a. m. r S. epidermidis E. faecalis  E. coli P. aeruginosa 
Hexane - - - -  - - 
Dichloromethane - - - +  - + 
Ethyl acetate + + + +  - + 
Methanol - - - +  - - 
Hydroalcolic - - - +  - - 
+: sensitive;-: not sensitive; S. a. m. r: Staphylococcus aureus meticillin resitant 
 
Table 3: Minimum Inhibitory Concentration and total activity of various extracts from A. ataxacantha 
 Minimum Inhibitory Concentration (mg/ml) 
Extracts Gram (+)  Gram (-) 
S. aureus S. a. m. r S. epidermidis E. faecalis  P. aeruginosa 
Dichloromethane - - - 0.625  0.625 
Ethyl acetate 0.325 0.625 0.625 0.625  0.625 
Methanol - - - 2.5  - 
Hydroalcolic - - - 2.5  5 
Total activity (ml) 
Dichloromethane - - - 8.02  8.02 
Ethyl acetate 43.32 22.53 22.53 22.53  22.53 
Methanol - - - 16.99  - 
Hydroalcolic - - - 41.36  20.68 
-: not sensitive; S. a. m. r: Staphylococcus aureus meticillin resitant 
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RESULTS 
Phytochemical analysis  
Phytochemical Constituents extracts of A. ataxacantha are shown in 
Table 1. On the whole, coumarins, flavonoids, alkaloids, derivatives 
of anthracene, lignans, tannins and triterpenes were identified in all 
extracts with the exception of the hexane extract. The ethyl acetate 
extract gave a positive result for all groups secondary metabolites 
investigate. Phytochemical tests have also shown the absence of 
saponins and naphthoquinone respectively in dichloromethane and 
methanol extracts. 
Antibacterial activity 
Growth inhibition effect of extracts at 10 mg/ml 
The purpose of this test was to eliminate the extracts did not inhibit 
the growth of bacteria at 10 mg/ml. In this study, both polar as well 
as non polar solvents were used for the extraction of active 
components from the bark of Acacia ataxacantha plant. The results 
(Table 2) showed that the tested bacteria are sensitive to one or 
more extracts. However, the dichloromethane, ethyl acetate, 
methanol and hydroalcolic extracts inhibited the growth of E. 
faecalis. It was noticed that the ethyl acetate extract inhibited the 
growth of all strains tested except E. coli while dichloromethane 
extract inhibited P. aeruginosa. The hexane extract of A. ataxacantha 
showed no inhibition of bacterial growth. The growth inhibitory 
activity exercised by dichloromethane and ethyl acetate extracts on 
the most studied strains (five germs out of six or 80% of cases for 
ethyl acetate extract and two germs on 6 or 35% of cases for 
dichloromethane extract) reflects the reality of an inherent 
antimicrobial property to A. ataxacantha bark with an antibacterial 
spectrum of action that affects indiscriminately Gram positive and 
Gram negative bacteria 
Minimum Inhibitory Concentration (MIC) and total activity 
The bacterium growth inhibition produced by A. ataxacantha 
extracts varied in relation to the type of extract and to the bacterium 
strain used. The Minimum Inhibitory Concentrations (MICs) and 
total activity of extracts are recorded in Table 3. The extracts 
showed MIC values ranging from 0.325 to 5 mg/ml. Ethyl acetate 
extract showed interesting activity against S. aureus with MIC values 
325 µg/ml. A MIC of 625 µg/ml was obtained with the same extract 
on the following strains: S. aureus meticillin resitant, S. epidermidis, 
E. faecalis and P. aeruginosa. The dichloromethane extract of A. 
ataxacantha inhibits the growth of E. faecalis and P. aeruginosa with 
a concentration of 625 µg/ml. Regarding the methanolic and 
hydroalcolic extracts, the minimum inhibitory concentration was 
respectively 2.5 mg/ml on E. feacalis and 5 mg/ml on P. aeruginosa. 
The extracts with higher total activity (TA) values are considered the 
best. The most interesting total activities of A. ataxacantha were 
obtained with ethyl acetate (43.32 ml) and hydroalcolic (41.36 ml) 
extracts against Staphylococus aureus and E. feacalis respectively. 
DISCUSSION 
Medicinal plants are the basis of therapeutic treatments in 
developing countries. Recent years have also seen an increase in the 
use of herbal medicines in developed countries. The plants are used 
medicinally in different countries of the world and are a good source 
of many potent and powerful drugs [15]. The resistance of 
pathogens to antibiotics commonly used, the increase in 
opportunistic infections and the effect of toxicity due to the 
continued use of several drugs have led to increased attention paid 
to the search for new therapeutic agents from various sources, 
including plants, which are good starting materials for the discovery 
of new antimicrobial agents [16, 17]. Secondary metabolites 
produced by plants constitute a source of bioactive substances. All 
over the world, plants scientist interest has increased due to the 
search for new drugs from plant origin. Secondary metabolites of 
plant have been reported to serve as defense mechanisms against 
predation by many microorganisms, insects and herbivores [18]. 
In the present study, phytochemical investigation and antibacterial 
activity were carried out on the barks of Acacia ataxacantha, an herb 
use traditionally in Benin to treat numerous diseases. Several 
species of genus Acacia have been studied and it has been 
demonstrated that they have hypoglycemic [19] anti-aggregation 
platelet effect [20], antigenotoxic and antimicrobial [21], 
antihypertensive, antispasmodic [22, 23] and anti-inflammatory 
activity [24]. 
The phytochemical examination of Acacia ataxacantha extracts indicated 
the presence of tannins, flavonoids, triterpenes, coumarins, lignans, 
pigments, saponins, alkaloids, anthracene derivatives and 
naphtoquinones. Some secondary metabolites have been reported in the 
literature to have interesting pharmacological activities.  
Our results showed that MIC values of extracts range from 0.325 to 5 
mg/ml. Ethyl acetate extract was the most active with MIC value of 
325 µg/ml against S. aureus. The activity of the ethyl acetate extract 
is higher compared to other extracts. This may be due to the capacity 
of ethyl acetate to extract compounds which have antibacterial 
properties. The dichloromethane extract of A. ataxacantha inhibited 
the growth of Pseudomonas aeruginosa with a MIC of 625 µg/ml. 
This means potent antibacterial activity of the dichloromethane 
extract considering the multidrug resistance of P. aeruginosa (gram 
negative bacteria) which is responsible for many nosocomial 
infections. The development of multidrug-resistant of P. aeruginosa 
is currently one of the biggest challenges to the effective 
management of infections [25]. The variation in the effectiveness of 
the extracts against different microorganisms may be attributed to 
the phytochemical composition of the extracts and/or membrane 
permeability of the microbes for the chemicals and their 
metabolism. 
Phytochemical study of ethyl acetate and dichloromethane extracts 
revealed the presence of tannins, flavonoids, triterpenes, coumarins, 
lignans, pigments, saponins, alkaloids, anthracene derivatives and 
naphtoquinones except saponins in dichloromethane extract. These 
results could justify the antibacterial activity of these extracts. 
Several studies have demonstrated the antibacterial potential of 
these secondary metabolites. Tannins inhibit the microbial growth 
by causing the bacterial colonies to disintegrate which probably 
results from their interference with the bacterial cell wall [26]. They 
precipitate proteins covering the surface of the cell or tissue, which 
acts as a barrier between tissue and irritants, and the underlying 
tissue is therefore soothed and protected from further damage, so 
that healing can take place [27]. Flavonoids have been found to 
exhibit antimicrobial activity through various mechanisms like 
inhibition of nucleic acid synthesis, inhibition of cytoplasmic 
membrane function and energy metabolism [28]. Plants containing 
tannins and flavonoids are used in the treatment of diarrhoea and 
dysentery [29, 30]. The phytochemical analysis of extracts also 
revealed the presence of naphthoquinones in dichloromethane and 
ethyl acetate extracts while the methanol and hydroalcolic extracts 
did not contain. The antibacterial effect of dichloromethane and 
ethyl acetate extracts could be due or accentuated by the presence of 
naphthoquinones. Some studies confirm the antibacterial effect of 
naphthoquinones [31, 32]. Generally, naphthoquinones are activated 
inside the microbial cells and become covalently attached to the 
cellular nucleophiles such as proteins and basic parts of DNA, often 
leading to inactivation of proteins and loss of function [33]. Others 
authors have also reported the antibacterial effect of triterpenes [34, 
35]. Their antimicrobial activity has associated with among other 
bacterial cell membrane disruption by the lipophilic compounds [36]. 
The presence of saponins in the ethyl acetate and hydroethanolic 
extracts and its absence in dichloromethane extract indicates that 
saponins do not play an essential role in inhibiting bacterial growth. 
Indeed, the mode of action of antibacterial effects of saponins seems to 
involve membranolytic properties [37]. They possess detergent like 
activity and might increase the permeability of the bacterial cell 
membrane without destroying them. In theory, this activity might 
facilitate antibiotic influx through the bacterial cell wall membrane [38]. 
The presence of active chemical groups such as tannins, 
naphthoquinones, triterpenes and flavonoids in the studied extracts 
could justify interesting results obtained and the indications of this 
plant in traditional medicine, particular for its antibacterial properties. 
Our results also confirm the antibacterial activity of A. ataxacantha as 
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a broad spectrum antimicrobial agent, since it inhibits the growth of 
Gram-positive and Gram-negative bacteria. Thus, these results support 
the use of A. ataxacantha in traditional medicines for the treatment of 
infections caused by bacteria tested in our study.  
CONCLUSION 
The acacia species used in this study had never been evaluated or 
only partially studied for antibacterial activity. At least, this plant 
seems to be of particular interest for further investigation, as it is 
effective against both gram-negative and gram-positive bacteria. It is 
an indication that the plant can be a source of bioactive substances. 
In addition, our results support the idea that herbal medicines with 
medicinal value have a promising future in regard to the discovery of 
new substances able to participate in the development of 
pharmaceutical products based drugs or improved traditional plant 
medicines (MTA). Bioguided fractionation of the corresponding 
extracts is under process. 
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